Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Delta-tocotrienol is a naturally occurring member of the vitamin E family, specifically one of the four tocotrienols (alpha, beta, gamma, and delta). It is found in various vegetable oils (such as palm oil), wheat germ, barley, and certain nuts and grains. Delta-tocotrienol has demonstrated anti-cancer activity in preclinical studies by accumulating in cancer cells and exerting effects through downregulation or degradation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, cell cycle arrest, induction of caspase-mediated apoptosis, inhibition of angiogenesis and metastasis pathways. It also induces endoplasmic reticulum stress leading to unfolded protein response activation. Clinical trials have explored its use as an adjunct therapy for chemotherapy-refractory ovarian cancer with promising disease stabilization rates[1][4][5][6][8]. As a dietary supplement ingredient it is marketed for cardiovascular health benefits such as cholesterol lowering[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on delta-tocotrienol.